REFERENCES
- Balakrishnan K., Sankar S., Parikh J., Padmavathi R., Srividya K., Venugopal V., Prasad S., Paney V. L. Daily average exposures to respirable particulate matter from combustion of biomass fuels in rural households of southern India. Environ. Health Perspect. 2002; 110: 1069–1075, [INFOTRIEVE], [CSA]
- Basu S. Radioimmunoassay of 5-keto-13,14-dihydro-prostaglandin F2α: An index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostaglandins Leukotrienes. Essential Fatty Acids 1998; 58: 347–352, [CROSSREF], [CROSSREF], [CSA]
- Basu S. Isoprostanes: Novel bioactive products of lipid peroxidation. Free Radical. Res. 2004; 38: 105–122, [CROSSREF], [CROSSREF], [CSA]
- Basu S., Whiteman M., Mattey D., Halliwell; B. Elevated levels of F2-isoprostanes and prostaglandin F2α in different rheumatic diseases. Ann. Rheum. Dis. 2001; 60: 627–631, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Blomberg A., Mudway I., Svensson M., Hagenbjork-Gustafsson A., Thomasson L., Helleday R., Dumont X., Forsberg B., Nordberg G., Bernard A. Clara cell protein as a biomarker for ozone-induced lung injury in humans. Eur. Respir. J. 2003; 22: 883–888, [INFOTRIEVE], [CSA]
- Boman B. C., Forsberg A. B., Järvholm B. G. Adverse health effects from ambient air pollution in relation to residential wood combustion in modern society. Scand. J. Work Environ. Health 2003; 29: 251–260, [INFOTRIEVE], [CSA]
- Chait A., Han C. Y., Oram J. F., Heinecke J. W. Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: Markers or mediators of cardiovascular disease?. J. Lipid Res. 2005; 46: 389–403, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Dockery D. W., Pope C. A., 3rd, Xu X., Spengler J. D., Ware J. H., Fay M. E., Ferris B. G., Jr, Speizer F. E. An association between air pollution and mortality in six U.S. cities. N. Engl. J. Med. 1993; 329: 1753–1759, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Donaldson K., Mills N., MacNee W., Robinson S., Newby D. Role of inflammation in cardiopulmonary health effects of PM. Toxicol. Appl. Pharmacol. 2005; 207: S483–S488, [CROSSREF], [CROSSREF], [CSA]
- Donaldson K., Stone V., Seaton A., MacNee W. Ambient particle inhalation and the cardiovascular system: Potential mechanisms. Environ. Health Perspect. 2001; 109: 523–527, [INFOTRIEVE], [CSA]
- Folsom A. R., Wu K. K., Rosamond W. D., Sharrett A. R., Chambless L. E. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 1997; 96: 1102–1108, [INFOTRIEVE], [CSA]
- Frampton M. W., Utell M. J., Zareba W., Oberdörster G., Cox C., Huang L. S., Morrow P. E., Lee F. E., Chalupa D., Fraiser L. M., Speers D. M., Stewart J. Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Res. Rep. Health Effects Inst. 2004; 126: 1–63, [CSA]
- Ghio A. J., Hall A., Bassett M. A., Cascio W. E., Devlin R. B. Exposure to concentrated ambient particles alters hematologic indices in humans. Inhal. Toxicol. 2003; 15: 1465–1478, [INFOTRIEVE], [CSA]
- Ghio A. J., Kim C., Devlin R. B. Concentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteers. Am. J. Respir. Crit. Care Med. 2000; 162: 981–988, [INFOTRIEVE], [CSA]
- Ghio A. J., Cohen M. D. Disruption of iron homeostasis as a mechanism of biological effect by ambient air pollution particles. Inhal. Toxicol. 2005; 17: 709–716, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Gilmour P. S., Ziesenis A., Morrison E. R., Vickers M. A., Drost E. M., Ford I., Karg E., Mossa C., Schroeppel A., Ferron G. A., Heyder J., Greaves M., MacNee W., Donaldson K. Pulmonary and systemic effects of short-term inhalation exposure to ultrafine carbon black particles. Toxicol. Appl. Pharmacol. 2004; 195: 35–44, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Gold D. R., Litonjua A., Schwartz J., Lovett E., Larson A., Nearing B., Allen G., Verrier M., Cherry R., Verrier R. Ambient air pollution and heart rate variability. Circulation 2000; 101: 1267–1273, [INFOTRIEVE], [CSA]
- Gong H., Jr, Linn W. S., Sioutas C., Terrell S. L., Clark K. W., Anderson K. R., Terell L. L. Controlled exposures of healthy and asthmatic volunteers to concentrated ambient fine particles in Los Angeles. Inhal. Toxicol. 2003; 15: 305–325, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Helmersson J., Larsson A., Vessby B., Basu S. Active smoking and a history of smoking are associated with enhanced prostaglandin F2α, interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 2005; 181: 201–207, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Hoek G., Brunekreef B., Goldbohm S., Fischer P., Van den Brandt P. A. Association between mortality and indicators of traffic-related air pollution in the Netherlands: A cohort study. Lancet 2002; 360: 1203–1209, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Holgate S. T., Devlin R. B., Wilson S. J., Frew A. J. Health effects of acute exposure to air pollution. Part II: Healthy subjects exposed to concentrated ambient particles. Res. Rep. Health Effects Inst. 2003; 112: 31–67, [CSA]
- Jenkins B. M., Jones A. D., Turn S. Q., Williams R. B. Particle concentrations, gas-particle partitioning, and species intercorrelations for polycyclic aromatic hydrocarbons (PAH) emitted during biomass burning. Atmos. Environ. 1996; 30: 3825–3835, [CROSSREF], [CROSSREF], [CSA]
- Jern C., Eriksson E., Tengborn L., Risberg B., Wadenvik H., Jern S. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb. Haemost. 1989; 62: 767–771, [INFOTRIEVE], [CSA]
- Kadir R. A., Economides D. L., Sabin C. A., Owens D., Lee C. A. Variations in coagulation factors in women: Effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb. Haemost. 1999; 82: 1456–1461, [INFOTRIEVE], [CSA]
- Katsouyanni K., Touloumi G., Spix C., Schwartz J., Balducci F., Medina S., Rossi G., Wojtyniak B., Sunyer J., Bacharova L., Schouten J. P., Ponka A., Anderson H. R. Short-term effects of ambient sulphur dioxide and particulate matter on mortality in 12 European cities: Results from time series data from the APHEA project. Air Pollution and Health: a European Approach. Br. Med. J. 1997; 314: 1658–1663, [CSA]
- Künzli N., Jerrett M., Mack W. J., Beckerman B., LaBree L., Gilliland F., Thomas D., Peters J., Hodis H. N. Ambient air pollution and atherosclerosis in Los Angeles. Environ. Health Perspect. 2005; 113: 201–206, [CSA]
- Liao D., Heiss G., Chinchilli V. M., Duan Y., Folsom A. R., Lin H. -M., Salomaa V. Association of criteria pollutants with plasma hemostatic/inflammatory markers: A population-based study. J. Expos. Anal. Environ. Epidemiol. 2005; 15: 319–328, [CROSSREF], [CROSSREF], [CSA]
- Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868–874, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- McDonald J. D., Zielinska B., Fujita E. M., Sagebiel J. C., Chow J. C., Watson J. G. Fine particle and gaseous emission rates from residential wood combustion. Environ. Sci. Technol. 2000; 34: 2080–2091, [CROSSREF], [CROSSREF], [CSA]
- Molnár P., Gustafson P., Johannesson S., Boman J., Barregard L., Sallsten G. Domestic wood burning and PM2.5 trace elements: Personal exposures, indoor and outdoor levels. Atmos. Environ. 2005; 39: 2643–2653, [CROSSREF], [CROSSREF], [CSA]
- Morrow J. D., Frei B., Longmire A. W., Gaziano J. M., Lynch S. M., Shyr Y., Strauss W. E., Oates J. A., Roberts L. J., II. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N. Engl. J. Med. 1995; 332: 1198–1203, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Mudway I. S., Stenfors N., Duggan S. T., Roxborough H., Zielinski H., Marklund S. L., Blomberg A., Frew A. J., Sandstrom T., Kelly F. J. An in vitro and in vivo investigation of the effects of diesel exhaust on human airway lining fluid antioxidants. Arch. Biochem. Biophys. 2004; 423: 200–212, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Mueller T., Dieplinger B., Gegenhuber A., Haidinger D., Schmid N., Roth N., Ebner F., Landl M., Poelz W., Haltmayer M. Serum total 8-iso-prostaglandin F2alpha: A new and independent predictor of peripheral arterial disease. J. Vasc. Surg. 2004; 40: 768–773, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Nafstad P., Haheim L. L., Wisloff T., Gram F., Oftedal B., Holme I., Hjermann I., Leren P. Urban air pollution and mortality in a cohort of Norwegian men. Environ. Health Perspect. 2004; 112: 610–615, [INFOTRIEVE], [CSA]
- Nemmar A., Hoet P. H., Vanquickenborne B., Dinsdale D., Thomeer M., Hoylaerts M. F., Vanbilloen H., Mortelmans L., Nemery B. Passage of inhaled particles into the blood circulation in humans. Circulation 2002; 105: 411–414, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Pekkanen J., Brunner E. J., Anderson H. R., Tiittanen P., Atkinson R. W. Daily concentrations of air pollution and plasma fibrinogen in London. Occup. Environ. Med. 2000; 57: 818–822, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Peters A., Doring A., Wichmann H. E., Koenig W. Increased plasma viscosity during an air pollution episode: a link to mortality?. Lancet 1997; 349: 1582–1587, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Pope C. A., III, Burnett R. T., Thun M. J., Calle E. E., Krewski D., Ito K., Thurston G. D. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. J. Am. Med. Assoc. 2002; 287: 1132–1141, [CROSSREF], [CROSSREF], [CSA]
- Pope C. A., III, Burnett R. T., Thurston G. D., Thun M. J., Calle E. E., Krewski D., Godleski J. J. Cardiovascular mortality and long-term exposure to particulate air pollution: Epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004; 109: 71–77, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Ridker P. M., Hennekens C. H., Buring J. E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 2000; 342: 836–843, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Riojas-Rodriguez H., Romano-Riquer P., Santos-Burgoa C., Smith K. R. Household firewood use and the health of children and women of Indian communities in Chiapas, Mexico. Int. J. Occup. Environ. Health 2001; 7: 44–53, [INFOTRIEVE], [CSA]
- Sállsten G., Gustafson P., Johanson L., Johannesson S., Molnár P., Strandberg B., Tullin C., Barregard L. Experimental wood smoke exposure in humans. Inhal. Toxicol. 2006; 18: 855–864, [CSA]
- Salvi S., Blomberg A., Rudell B., Kelly F., Sandstrom T., Holgate S. T., Frew A. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am. J. Respir. Crit. Care Med. 1999; 159: 702–709, [INFOTRIEVE], [CSA]
- Salvi S., Nordenhall C., Blomberg A., Rudell B., Pourazar J., Kelly F. J., Wilson S., Sandstrom T., Holgate S. T., Frew A. J. Acute exposure to diesel exhaust increases IL-8 and GRO-alpha production in healthy human airways. Am. J. Respir. Crit. Care Med. 2000; 161: 550–557, [INFOTRIEVE], [CSA]
- Samet J. M., Dominici F., Curriero F. C., Coursac I., Zeger S. L. Fine particulate air pollution and mortality in 20 U.S. cities, 1987–1994. N. Engl. J. Med. 2000; 343: 1742–1749, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Schambeck C. M., Grossmann R., Zonnur S., Berger M., Teuchert K., Spahn A., Walter U. High factor VIII (FVIII) levels in venous thromboembolism: Role of unbound FVIII. Thromb. Haemost. 2004; 92: 42–46, [INFOTRIEVE], [CSA]
- Schwartz J. Air pollution and blood markers of cardiovascular risk. Environ. Health Perspect. 2001; 109: 405–409, [INFOTRIEVE], [CSA]
- Seaton A., MacNee W., Donaldson K., Godden D. Particulate air pollution and acute health effects. Lancet 1995; 345: 176–178, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Traynor G. W., Apie M. G., Carruthers A. R., Dillworth D. T., Gundel L. A. Indoor air pollution due to emissions from wood-burning stoves. Environ. Sci. Technol. 1987; 21: 691–697, [CROSSREF], [CROSSREF], [CSA]
- Wang B., Pan J., Wang L., Zhu H., Yu R., Zou Y. Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis 2006; 184: 425–430, [INFOTRIEVE], [CROSSREF], [CROSSREF], [CSA]
- Wells P. S., Langlois N. J., Webster M. A., Jaffey J., Anderson J. A. Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada—Is it necessary to define a new upper reference range for factor VIII?. Thromb. Haemost. 2005; 93: 842–846, [INFOTRIEVE], [CSA]